Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.40 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.40 |
| ▸ | ATM | Q13315 | 1/20 | 0.40 |
| ▸ | PTGER4 | P35408 | 1/20 | 0.32 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.31 |
| ▸ | IL1R1 | P14778 | 1/20 | 0.31 |
| ▸ | MEN1 | O00255 | 2/20 | 0.30 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.30 |
| ▸ | MAPT | P10636 | 2/20 | 0.30 |
| ▸ | HTT | P42858 | 1/20 | 0.30 |
| ▸ | ABCG2 | Q9UNQ0 | 1/20 | 0.30 |
| ▸ | RXFP1 | Q9HBX9 | 1/20 | 0.30 |
| ▸ | HPGD | P15428 | 1/20 | 0.30 |
| ▸ | JAK2 | O60674 | 1/20 | 0.30 |
| ▸ | JAK3 | P52333 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21747099 | 0.96 | KDM4E (0.38) | L3MBTL1KDM4EATMPTGER4KMT2A | |
| SCHEMBL18561384 | 0.94 | KDM4E (0.36) | L3MBTL1KDM4EATMPTGER4 | |
| SCHEMBL21746818 | 0.93 | KDM4E (0.38) | L3MBTL1KDM4EATMPTGER4RXFP1 | |
| SCHEMBL20177062 | 0.92 | L3MBTL1 (0.36) | L3MBTL1KDM4EATMPTGER4KMT2A | |
| SCHEMBL22137211 | 0.92 | ABCG2 (0.35) | L3MBTL1KDM4EATMKMT2AMEN1 | |
| SCHEMBL23127800 | 0.91 | L3MBTL1 (0.40) | L3MBTL1KDM4EATMPTGER4KMT2A | |
| SCHEMBL20177057 | 0.91 | L3MBTL1 (0.42) | L3MBTL1KDM4EATMPTGER4KMT2A | |
| SCHEMBL26708570 | 0.90 | L3MBTL1 (0.39) | L3MBTL1KDM4EATMPTGER4KMT2A | |
| SCHEMBL23127603 | 0.90 | KDM4E (0.36) | L3MBTL1KDM4EATMPTGER4KMT2A | |
| SCHEMBL23347820 | 0.90 | KDM4E (0.34) | L3MBTL1KDM4EATM |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10833276-B2 | Organic electroluminescent materials and devices | UNIVERSAL DISPLAY CORPORATION (US) | 2020-11-10 | — | — | US | disclosed |
| US-20180145262-A1 | Organic Electroluminescent Materials and Devices | UNIVERSAL DISPLAY CORPORATION | 2018-05-24 | — | — | US | disclosed |
| US-20180145262-A1 | Organic Electroluminescent Materials and Devices | UNIVERSAL DISPLAY CORPORATION | 2018-05-24 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10833276-B2 | Organic electroluminescent materials and devices | OCIAD2, OCIAD1, TYR | L3MBTL1 239/4885KDM4E 3046/4885ATM 590/4885 |
| US-20180145262-A1 | Organic Electroluminescent Materials and Devices | OCIAD2, OCIAD1, TYR | L3MBTL1 239/4885KDM4E 3046/4885ATM 590/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.